IMMUNOSUPPRESSOR AGENT DERIVED FROM MORBILLIVIRUS

摘要

The invention relates to the use of morbillivirus nucleoproteins, or fragments thereof comprising the C-terminal portion of 100 to 130 amino acids for the preparation of immunosuppressor drugs, and to the use of morbilliviruses within which the C-terminal portion has been deleted or altered, for the preparation of vaccines.